- Home
- FSLR vs BAX Comparison
FSLR vs BAX Comparison
Compare FSLR & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSLR
- BAX
- Stock Information
- Founded
- FSLR 1999
- BAX 1931
- Country
- FSLR United States
- BAX United States
- Employees
- FSLR N/A
- BAX N/A
- Industry
- FSLR Semiconductors
- BAX Medical/Dental Instruments
- Sector
- FSLR Technology
- BAX Health Care
- Exchange
- FSLR Nasdaq
- BAX Nasdaq
- Market Cap
- FSLR 13.1B
- BAX 15.6B
- IPO Year
- FSLR 2006
- BAX N/A
- Fundamental
- Price
- FSLR $158.08
- BAX $30.49
- Analyst Decision
- FSLR Strong Buy
- BAX Buy
- Analyst Count
- FSLR 30
- BAX 8
- Target Price
- FSLR $232.68
- BAX $37.25
- AVG Volume (30 Days)
- FSLR 6.0M
- BAX 3.5M
- Earning Date
- FSLR 07-29-2025
- BAX 05-01-2025
- Dividend Yield
- FSLR N/A
- BAX 2.23%
- EPS Growth
- FSLR 23.43
- BAX N/A
- EPS
- FSLR 11.77
- BAX N/A
- Revenue
- FSLR $4,256,749,000.00
- BAX $10,771,000,000.00
- Revenue This Year
- FSLR $21.82
- BAX $8.06
- Revenue Next Year
- FSLR $19.16
- BAX $4.19
- P/E Ratio
- FSLR $13.43
- BAX N/A
- Revenue Growth
- FSLR 19.42
- BAX 15.36
- 52 Week Low
- FSLR $116.56
- BAX $26.25
- 52 Week High
- FSLR $306.77
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- FSLR 53.73
- BAX 47.96
- Support Level
- FSLR $153.77
- BAX $29.72
- Resistance Level
- FSLR $161.62
- BAX $31.04
- Average True Range (ATR)
- FSLR 9.52
- BAX 0.72
- MACD
- FSLR -1.90
- BAX -0.03
- Stochastic Oscillator
- FSLR 27.55
- BAX 26.01
About FSLR First Solar Inc.
First Solar designs and manufactures solar photovoltaic panels, modules, and systems for use in utility-scale development projects. The company's solar modules use cadmium telluride to convert sunlight into electricity. This is commonly called thin-film technology. First Solar is the world's largest thin-film solar module manufacturer. It has production lines in Vietnam, Malaysia, the United States, and India.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.